Achieve Life Sciences (ACHV)
Develops cytisinicline for nicotine dependence across smoking-cessation and vaping-cessation programs.
$8.22
After hours+0.09 (+1.11%)
At close$8.13(+0.99%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | ≈ 80.45% | 82.79M shares | |
|---|---|---|---|
| 119 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 0.94% | 966.0K shares | |
| 8 holders · as of Aug 21, 2026 | |||
| Strategic holders | 5.35% | 5.50M shares | |
| 1 holder · as of Aug 13, 2026 | |||
| Other | ≈ 13.26% | 13.65M shares | |
| remainder | |||
102.90M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
13F, as of Jun 30, 2026
119 holders · 82.79M shares · 51 new positions · 88 increased · 13 reduced · 18 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 7.61M | 7.40% | +7.61Mnew | Aug 14, 2026 |
| TPG GP A, LLC | 6.88M | 6.68% | +6.88Mnew | Aug 14, 2026 |
| Venbio Partners LLC | 5.91M | 5.75% | +5.91Mnew | Aug 14, 2026 |
| Logos Global Management LP | 5.43M | 5.27% | +5.43Mnew | Aug 14, 2026 |
| BlackRock, Inc. | 5.27M | 5.12% | +4.83M | Aug 7, 2026 |
| Franklin Resources Inc | 4.95M | 4.81% | +584.0K | Aug 13, 2026 |
| Paradigm Biocapital Advisors LP | 4.95M | 4.81% | +4.95Mnew | Aug 14, 2026 |
| Vanguard Capital Management LLC | 4.14M | 4.02% | +1.94M | Aug 13, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| TPG GP A, LLCincl. Jon Winkelried, James G. Coulter | 12.60% | 13.76M | 13D | Apr 24, 2026 |
| Logos Global Management LP | 9.99% | 10.54M | 13G | Aug 17, 2026 |
| venBio Global Strategic GP V, LLCincl. venBio Global Strategic Fund V, L.P. | 9.99% | 10.74M | 13D | Apr 27, 2026 |
| Paradigm BioCapital Advisors LP | 9.20% | 9.90M | 13G | Apr 24, 2026 |
| Frazier Life Sciences Public Fund, L.P. | 6.50% | 6.63M | 13G | Apr 24, 2026 |
| Franklin Resources, Inc. | 6.20% | 6.37M | 13G | May 7, 2026 |
| Alyeska Investment Group, L.P. | 5.60% | 2.98M | 13G | Nov 14, 2025 |
| JANUS HENDERSON GROUP Ltd. | 5.40% | 5.50M | 13G | Aug 13, 2026 |
| Venrock Healthcare Capital Partners III, L.P. | 5.20% | 5.50M | 13G | Apr 24, 2026 |
| BlackRock, Inc. | 5.10% | 5.27M | 13G | Jul 27, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 19, 2026 | Richard Alistair Stewartdirector | Sale | 20,626 | $8.49 | 208,249 |
| Sep 18, 2025 | Richard Alistair Stewartdirector, officer: Chief Executive Officer | Sale | 129,501 | $2.92 | 228,875 |
| Sep 18, 2025 | Mark K. Okiofficer: Chief Financial Officer | Sale | 50,060 | $2.92 | 127,940 |
House and Senate disclosures
Not reported.